Testosterone Undecanoate (Nebido/Aveed)

Overview

Testosterone undecanoate is a long-acting injectable form of testosterone used for testosterone replacement therapy (TRT). It is marketed as Aveed in the United States and as Nebido (and Reandron in some markets) elsewhere. The “undecanoate” part refers to the fatty-acid ester attached to the testosterone molecule, which slows its release from an oil-based depot.

Because of that slow release, it is the longest-interval injectable testosterone available: after an initial loading phase, maintenance injections are spaced much further apart than the weekly or biweekly shots used with shorter esters. This is one of its main appeals for people seeking fewer injections.

Unlike most TRT options, the US product is administered in a clinical setting rather than self-injected at home, owing to a specific safety warning discussed below.

How it works

Testosterone undecanoate is a prodrug: once injected into muscle, the ester is gradually cleaved, releasing testosterone into the bloodstream over an extended period. This produces relatively stable testosterone levels compared with the peaks and troughs that can accompany shorter-acting esters. The released testosterone then acts on the androgen receptor like the body’s own testosterone, supporting the tissues and functions that depend on it.

Clinical studies in men with hypogonadism have reported that the formulation restores testosterone into the normal range and is generally well tolerated over repeated dosing cycles.

Reported benefits

• Restoration of testosterone levels in men diagnosed with hypogonadism (studied)
• Reported improvements in libido and sexual function in hypogonadal men
• Fewer injections than shorter-acting testosterone esters
• More stable testosterone levels with less pronounced peak-and-trough fluctuation (reported)
• Improvements in body composition, such as reduced fat mass, reported in some hypogonadal cohorts

These are reported and studied effects in men with diagnosed testosterone deficiency, not guaranteed outcomes.

Considerations & side effects

The defining safety consideration is a boxed warning for pulmonary oil microembolism (POME) and anaphylaxis. These reactions — which can include coughing, shortness of breath, throat tightness, chest pain, dizziness, or fainting — may occur during or immediately after an injection, including after the first dose. For this reason the US product is dispensed through a restricted program and given in a healthcare setting where the patient can be observed afterward.

Beyond that, testosterone undecanoate shares the general considerations of testosterone therapy, which can include changes in red blood cell count, effects on fertility, mood or acne changes, and the need for monitoring of prostate and cardiovascular health. Its long duration also means that if side effects arise, the drug cannot be quickly withdrawn from the body. It is a prescription medication and is not a substitute for evaluation and monitoring by a qualified clinician.